Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice ; volume:22 ; number:1 ; day:3 ; month:1 ; year:2024 ; pages:1-14 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (3.1.2024), 1-14, 12.2024
- Creator
-
Barajas, Ana
Amengual-Rigo, Pep
Pons-Grífols, Anna
Ortiz, Raquel
Gracia Carmona, Oriol
Urrea, Victor
Iglesia, Nuria de la
Blanco-Heredia, Juan
Anjos-Souza, Carla
Varela, Ismael
Trinité, Benjamin
Tarrés-Freixas, Ferran
Rovirosa, Carla
Lepore, Rosalba
Vázquez, Miguel
Mattos-Arruda, Leticia de
Valencia, Alfonso
Clotet, Bonaventura
Aguilar-Gurrieri, Carmen
Guallar, Victor
Carrillo, Jorge
Blanco, Julià
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04843-8
- URN
-
urn:nbn:de:101:1-2024031814390277071203
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Barajas, Ana
- Amengual-Rigo, Pep
- Pons-Grífols, Anna
- Ortiz, Raquel
- Gracia Carmona, Oriol
- Urrea, Victor
- Iglesia, Nuria de la
- Blanco-Heredia, Juan
- Anjos-Souza, Carla
- Varela, Ismael
- Trinité, Benjamin
- Tarrés-Freixas, Ferran
- Rovirosa, Carla
- Lepore, Rosalba
- Vázquez, Miguel
- Mattos-Arruda, Leticia de
- Valencia, Alfonso
- Clotet, Bonaventura
- Aguilar-Gurrieri, Carmen
- Guallar, Victor
- Carrillo, Jorge
- Blanco, Julià
- SpringerLink (Online service)
Other Objects (12)
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants
Thermally-responsive Virus-like Particle for Targeted Delivery of Cancer Drug
Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
Author Correction: Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
A pH‐Responsive Virus‐Like Particle as a Protein Cage for a Targeted Delivery
Virus-like particle vaccinology, from bench to bedside
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2
Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants
Thermally-responsive Virus-like Particle for Targeted Delivery of Cancer Drug
Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
Author Correction: Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
A pH‐Responsive Virus‐Like Particle as a Protein Cage for a Targeted Delivery
Virus-like particle vaccinology, from bench to bedside
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2
Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants
Thermally-responsive Virus-like Particle for Targeted Delivery of Cancer Drug
Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
Author Correction: Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
A pH‐Responsive Virus‐Like Particle as a Protein Cage for a Targeted Delivery
Virus-like particle vaccinology, from bench to bedside
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2